<h2 id="introduction">Introduction</h2> <p>Endpoints in clinical trials are pivotal for assessing the efficacy and safety of treatments. Primary endpoints, such as hemostatic efficacy, are the primary...
<h2 id="introduction">Introduction</h2> <p>Endpoints in clinical trials are pivotal for assessing the efficacy and safety of treatments. Primary endpoints, such as hemostatic efficacy, are the primary outcomes that trials aim to evaluate. For instance, in a study involving 263 patients receiving andexanet for intracranial bleeding, the primary endpoints included hemostatic efficacy and the NIH Stroke Scale score.</p> <p>These endpoints are crucial for determining whether a treatment meets its primary objectives.</p> <p>Secondary endpoints provide broader insights into the treatment's effects. They allow researchers to explore additional benefits or adverse effects not captured by primary endpoints. For example, in the OCEANIC AF trial, while the primary focus was on stroke risk reduction in patients with atrial fibrillation, secondary endpoints would help understand other impacts of the treatment.</p> <p>Understanding…